Recombinant humanized antibody expressed in CHO binding to human TFPI. Concizumab is a monoclonal IgG4 antibody (mAb) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI thereby blocking the interaction of this domain with the active site of FXa.
Figure 1 PK result of the antibody.
Mean PK profiles of concizumab concentration (log scale) up to 43 days after i.v. and s.c. administration of concizumab or placebo to healthy volunteers and hemophilia patients.
Chowdary, P., Lethagen, S., Friedrich, U., Brand, B., Hay, C., Abdul Karim, F.,... & Miesbach, W. (2015). Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis, 13(5), 743-754.
Figure 2 ELISA result of the antibody.
Mean free TFPI plasma concentration (ng mL−1) evaluated by TFPI ELISA up to 43 days after i.v. and s.c. administration of concizumab or placebo to healthy volunteers and hemophilia patients.
Chowdary, P., Lethagen, S., Friedrich, U., Brand, B., Hay, C., Abdul Karim, F.,... & Miesbach, W. (2015). Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis, 13(5), 743-754.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-TFPI ADCC Recombinant Antibody (Concizumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human TFPI. Concizumab is a monoclonal IgG4 antibody (mAb) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI thereby blocking the interaction of this domain with the active site of FXa.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-718 | Human Anti-TFPI Recombinant Antibody (clone mAb 2021) | Block | Human IgG |
PABC-461 | Mouse Anti-TFPI Recombinant Antibody (PABC-461) | FuncS, ELISA, FC, Neut | Mouse IgG1, κ |
HPAB-2592LY | Human Anti-TFPI Recombinant Antibody (HPAB-2592LY) | ELISA, WB, FuncS | Human IgG |
HPAB-2593LY | Human Anti-TFPI Recombinant Antibody (HPAB-2593LY) | ELISA, WB, FuncS | Human IgG |
HPAB-2594LY | Human Anti-TFPI Recombinant Antibody (HPAB-2594LY) | ELISA, WB, FuncS | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-3547 | Rabbit Anti-TFPI Recombinant Antibody (clone DS3547AB) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0488-CN-S(P) | Human Anti-TFPI Recombinant Antibody; scFv Fragment (HPAB-0488-CN-S(P)) | ELISA, FC | Human scFv |
HPAB-0495-YJ-S(P) | Human Anti-TFPI Recombinant Antibody; scFv Fragment (HPAB-0495-YJ-S(P)) | ELISA, WB, FuncS | Human scFv |
HPAB-0496-YJ-S(P) | Human Anti-TFPI Recombinant Antibody; scFv Fragment (HPAB-0496-YJ-S(P)) | ELISA, WB, FuncS | Human scFv |
HPAB-0591-YJ-S(P) | Mouse Anti-TFPI Recombinant Antibody; scFv Fragment (HPAB-0591-YJ-S(P)) | ELISA, FC, Neut, FuncS | Mouse scFv |
HPAB-0592-YJ-S(P) | Mouse Anti-TFPI Recombinant Antibody; scFv Fragment (HPAB-0592-YJ-S(P)) | ELISA, FC | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0429-YC-F(E) | Human Anti-TFPI Recombinant Antibody (clone TFPI-118); Fab Fragment | ELISA, FC, FuncS | Human Fab |
HPAB-0431-YC-F(E) | Human Anti-TFPI Recombinant Antibody; Fab Fragment (HPAB-0431-YC-F(E)) | ELISA, FC | Human Fab |
HPAB-2619LY-F(E) | Human Anti-TFPI Recombinant Antibody; Fab Fragment (HPAB-2619LY-F(E)) | ELISA, WB, FuncS | Human Fab |
HPAB-2620LY-F(E) | Human Anti-TFPI Recombinant Antibody; Fab Fragment (HPAB-2620LY-F(E)) | ELISA, WB, FuncS | Human Fab |
HPAB-2621LY-F(E) | Human Anti-TFPI Recombinant Antibody; Fab Fragment (HPAB-2621LY-F(E)) | ELISA, WB, FuncS | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-734 | Afuco™ Anti-TFPI ADCC Recombinant Antibody (Concizumab), ADCC Enhanced | ELISA, IP, FC, FuncS, Neut, IF | ADCC enhanced antibody |
There are currently no Customer reviews or questions for TAB-734. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.